Show Notes
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 2 of 4.
My guest today is Mark Kotter, neurosurgeon, stem cell biologist, and CEO and Founder of bit.bio. Bit.bio is an award-winning human synthetic biology company providing human cells for research, drug discovery and cell therapy.
Bit.bio applies a patented safe harbor gene-targeting approach to inducibly express transcription factor combinations that reprogram human induced pluripotent stem cells into highly defined and mature human cell types.
In addition to bit.bio, Mark is also the Co-Founder of Meatable, Scientific Founder and Chairman of rejuvenation start-up clock.bio, and Co-Founder and trustee of Myelopathy.org, the first charity dedicated to a common yet often overseen condition causing a “slow motion spinal cord injury.”
Mark has also been a professor and researcher at Cambridge for more than 15 years. His diverse experience as an academic and serial entrepreneur offers a wealth of insights aspiring scientist-founders can draw from.
Join us this week and hear about Mark’s:
- Transition from his PhD studies at Cambridge to the Medical University of Vienna, where he became a resident in neurosurgery and ran his own research group
- Experience at the Max Planck Institute for Experimental Medicine
- Return to Cambridge, where he combined clinical practice with research
- Shift from academia to entrepreneurship, which led to the founding of his first biotech startup
Please enjoy my conversation with Mark Kotter.
Resources & Articles
Max Planck Institute for Experimental Medicine https://maxplanckneuroscience.org/institute/mpi-exp-medicine/
University of Cambridge https://www.cam.ac.uk/
Neurosurgery https://www.ohsu.edu/school-of-medicine/neurosurgery/what-neurosurgery
Cell Programing https://youtu.be/jrVQXHmxH7Y?si=csFYmCfaqkQFm95y
Differentiation Protocols https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405110/
Direct reprogramming protocols https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161510/
Synthetic Biology https://en.wikipedia.org/wiki/Synthetic_biology
Opti-ox Technology https://www.bit.bio/platform
How to Spin Out of Academia https://www.excedr.com/resources/how-to-spin-out-of-academia-and-into-a-startup
Organizations & People
Roger Pedersen https://www.linkedin.com/in/roger-pedersen-0b231115/
Harold Weintraub https://en.wikipedia.org/wiki/Harold_M._Weintraub
Marius Wernig https://med.stanford.edu/profiles/marius-wernig
Thomas Südhof https://med.stanford.edu/sudhoflab/about-thomas-sudhof.html
Shinya Yamanaka https://en.wikipedia.org/wiki/Shinya_Yamanaka